. Author manuscript; available in PMC: 2017 Mar 1.

Published in final edited form as: J Heart Lung Transplant. 2015 Oct 30;35(3):362–369. doi: 10.1016/j.healun.2015.10.028

Table 4b. Association between Age Groups and 5-Year Mortality among Transplant Recipients from June 30, 2004 to March 27, 2014.

		Unadjusted		Adjusted ^a
Outcome	Variable	HR (95% CI)	P-value	HR (95% CI)	P-value
5-Year Mortality	Age (60-69) vs. Age (18-59)	1.09 (1.02, 1.18)	0.02	1.10 (1.02, 1.19)	0.02
	Age (70+) vs. Age (18-59)	1.23 (0.99, 1.52)	0.06	1.24 (1.00, 1.54)	0.05
	Age (70+) vs. Age (60-69)	1.12 (0.90, 1.40)	0.30	1.13 (0.90, 1.41)	0.28

Adjustment variables: Recipient: VAD (Yes/No), gender, race, ischemic etiology, creatinine, condition at transplant, mechanical support (ECMO, IABP, ventilator, or other), pharmacological support (prostaglandins, inotropes, or inhaled NO), diabetes. Donor: CDC high risk, ischemic time, age, diabetes, smoking history, cause of death (head trauma, stroke, anoxia, other). Gender mismatch. Year of transplant.